Vyant Bio Inc

NASDAQ:VYNT   10:46:58 AM EDT
1.88
+0.12 (+6.82%)
Earnings Announcements

Vyant Bio Reports Third Quarter 2021 Results And Provides Strategic Business Updates

Published: 11/11/2021 21:09 GMT
Vyant Bio Inc (VYNT) - Vyant Bio Reports Third Quarter 2021 Results and Provides Strategic Business Updates.
Q3 Revenue $1.5 Million.
Qtrly Loss per Share $0.15.
Revenue is expected to be $1.59 Million
Adjusted EPS is expected to be -$0.16

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be $0.00

More details on our Analysts Page.